Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
about
Fibrates for secondary prevention of cardiovascular disease and strokeFibrates for secondary prevention of cardiovascular disease and strokeCould metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease?Differential expression of microRNAs in different disease states.PPARalpha deficiency reduces insulin resistance and atherosclerosis in apoE-null miceStatin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IInvestigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormoneEffects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer.Peroxisome proliferator-activated receptor α activates human multidrug resistance transporter 3/ATP-binding cassette protein subfamily B4 transcription and increases rat biliary phosphatidylcholine secretionLipid-lowering drugs in lupus: an unexplored therapeutic intervention.Gene expression and physiologic responses of the heart to the initiation and withdrawal of caloric restriction.Effects of conjugated linoleic acid, fish oil and soybean oil on PPARs (α & γ) mRNA expression in broiler chickens and their relation to body fat depositsProstanoids and their receptors that modulate dendritic cell-mediated immunity.Lipid-lowering drugs.Effects of Bacillus licheniformis on the growth performance and expression of lipid metabolism-related genes in broiler chickens challenged with Clostridium perfringens-induced necrotic enteritisThe peroxisome proliferator-activated receptor-gamma agonist pioglitazone represses inflammation in a peroxisome proliferator-activated receptor-alpha-dependent manner in vitro and in vivo in mice.PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.The natural carotenoid astaxanthin, a PPAR-α agonist and PPAR-γ antagonist, reduces hepatic lipid accumulation by rewiring the transcriptome in lipid-loaded hepatocytes.Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer ceTargeting high-density lipoproteins: increasing de novo production versus decreasing clearance.Involvement of Inflammatory Cytokines in Antiarrhythmic Effects of Clofibrate in Ouabain-Induced Arrhythmia in Isolated Rat Atria.Influence of betaine and arginine supplementation of reduced protein diets on fatty acid composition and gene expression in the muscle and subcutaneous adipose tissue of cross-bred pigs.Synthesis and anti-diabetic activity of (RS)-2-ethoxy-3-{4-[2-(4-trifluoro-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acid.Blood Lipid Distribution, Aortic Cholesterol Concentrations, and Selected Inflammatory and Bile Metabolism Markers in Syrian Hamsters Fed a Standard Breeding Diet.The induction of atherogenic dyslipidaemia in poloxamer 407-treated mice is not mediated through PPARalpha.Evaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism.PPAR Could Contribute to the Pathogenesis of Hepatocellular Carcinoma.Circulating free fatty acids are increased independently of PPARgamma activity after administration of poloxamer 407 to mice.Peroxisome proliferator-activated receptor-alpha ligands inhibit cardiac lipoprotein lipase activity.Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells.Peroxisome proliferator-activated receptor ligands as antiatherogenic agents: panacea or another Pandora's box?Fenofibrate inhibits reactive amyloidosis in mice.Fibrates and medroxyprogesterone acetate induce apoptosis of primary Burkitt's lymphoma cells and cell lines: potential for applying old drugs to a new disease.Inhibition of cholesterol absorption associated with a PPAR alpha-dependent increase in ABC binding cassette transporter A1 in mice.Effect of polyunsaturated fatty acids on the expression of transcription factor adipocyte determination and differentiation-dependent factor 1 and of lipogenic and fatty acid oxidation enzymes in porcine differentiating adipocytes.Cardiovascular disease is associated with high-fat-diet-induced liver damage and up-regulation of the hepatic expression of hypoxia-inducible factor 1α in a rat model.Gene expression profiling of the PPAR-alpha agonist ciprofibrate in the cynomolgus monkey liver.Intestinal epithelial Toll-like receptor 4 prevents metabolic syndrome by regulating interactions between microbes and intestinal epithelial cells in mice.The peroxisome proliferator-activated receptor alpha L162V mutation is associated with reduced adiposity.Influence of virgin coconut oil-enriched diet on the transcriptional regulation of fatty acid synthesis and oxidation in rats - a comparative study.
P2860
Q24186376-D023A935-6745-4AB6-9297-267FBDD6172AQ24204000-1A00F70D-8746-44F8-9EE0-4FFD5514002BQ26824893-8B423E37-F02F-4FBE-BFB9-64922202F73DQ27693279-B9AED988-2FC1-4E3C-B170-55AF53335B54Q28362804-4DA2A515-550F-4D44-8FA0-584D1F1C665DQ28366335-EA741A32-8ADF-44EE-966D-29ED80DC208DQ28566344-B89D9E0C-F64B-4E46-A8A7-DFFD13505CEBQ28589921-41B84BDA-9442-4FD8-9CE1-DBC61F82D2BCQ33725965-21259462-AD3F-4C19-B6AA-EC958FB54D10Q34227152-D4DB62E5-A80E-447C-9606-62D80EFCEBC1Q34566008-1094B3CC-2B00-4DA7-ABC6-B919CF6B2B7BQ35669453-A30F0F9E-95F3-4B6E-BE2C-464057BD6ACDQ35850629-AC9F4DE2-D8CE-4F0D-AF5D-8DA7B8B76FFEQ36002780-DF807681-2304-478F-A370-1E00D0696AF8Q36662980-B24B9180-0073-493D-AC6A-23A36F87E141Q37079828-81F65392-D9E0-427B-9402-E460BFC795EAQ37632735-875088F3-6EC7-47AC-9172-FD794274B8BDQ38324364-21F32839-C9EB-419F-8650-25756233F93DQ38338094-B56FD394-081C-490E-B527-6B7D8F346223Q38431166-193CDC3D-E640-4013-8BEF-58D977C36C65Q38606193-899EF108-DA6A-4945-968B-E5261AF9A142Q40051130-B690AA32-FF00-4426-848D-7B1E08DF2F3CQ40289987-E2734AF9-AB5F-48ED-A412-675262AE8961Q40680065-1DD83D1A-31B8-4D3F-84FF-A521B3BE9E3EQ41190747-A2741B1C-1755-4DA7-A1F6-E736C16FA319Q42048511-A4D2DB14-BD91-49FD-A4EF-27110827F6C7Q42125206-B8C6640B-AB4D-4815-8E6A-AFF5FDBD5AE4Q43210398-259F9DE2-6F45-4BD5-8012-83E22F251B61Q43675214-6FBC3052-6CBC-4681-9597-052C8B7509A2Q43760306-308C6089-33D6-41FA-8F05-25AAF257099FQ43986735-C43CD6CF-C192-4A12-B359-DCDFF4C3FD21Q44062265-DF2B554B-66E4-4CC4-A362-4194A1F2F4A4Q44368783-F10E1A4D-EF4D-4953-961B-9BCFC49B448AQ44535882-343452CF-16F3-49A8-A13A-9A94E477F731Q44586013-7129CCE4-C215-4212-9536-A90D452F0767Q45014583-6D8C0637-90C5-4642-9778-9F535F3D748FQ46635717-0326AC4C-6101-46E5-8FD2-F6566BA66A0EQ49831832-DDDF010F-805C-46DA-8E78-F2F6CBE436D8Q53647540-300D3B41-1461-49D3-91AD-36B13AAE2841Q54223483-4B1A1EB8-DF5E-4C19-9DBD-7750919AEC3E
P2860
Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@ast
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@en
type
label
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@ast
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@en
prefLabel
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@ast
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@en
P1476
Peroxisome proliferator-activa ...... on, atherosclerosis and aging.
@en
P2093
Pineda Torra I
P304
P356
10.1097/00041433-199904000-00009
P50
P577
1999-04-01T00:00:00Z